SCHEMBL8075665

SCHEMBL8075665

CC(C)N1C(=O)C(NC(=O)CCc2ccc(Cl)cc2Cl)C(=O)N(C(C)C)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.49
P2RX7 Q99572 4/20 0.43
TNKS O95271 2/20 0.43
TNKS2 Q9H2K2 1/20 0.43
PARP2 Q9UGN5 1/20 0.43
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
F10 P00742 1/20 0.41
PDPK1 O15530 1/20 0.41
HPGD P15428 1/20 0.41
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PPARG P37231 2/20 0.39
SIGMAR1 Q99720 1/20 0.39
CCKBR P32239 2/20 0.38
PLAAT3 P53816 1/20 0.38
PLAAT5 Q96KN8 1/20 0.38
PLAAT2 Q9NWW9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7046124 0.92 CCKBR (0.49) KCNH2P2RX7TNKSTNKS2PARP2
SCHEMBL8075696 0.89 SIGMAR1 (0.49) KCNH2P2RX7MAPTSIGMAR1
SCHEMBL8800786 0.83 KCNH2 (0.45) KCNH2P2RX7TNKSTNKS2PARP2
SCHEMBL7860301 0.83 KCNH2 (0.45) KCNH2P2RX7TNKSTNKS2PARP2
SCHEMBL7817774 0.83 KCNH2 (0.48) KCNH2P2RX7TNKSTNKS2PARP2
SCHEMBL8075666 0.82 KCNH2 (0.55) KCNH2P2RX7MAPTKDM4EALDH1A1
SCHEMBL8761175 0.80 KCNH2 (0.71) KCNH2CCKBR
SCHEMBL8761087 0.80 KCNH2 (0.71) KCNH2CCKBR
SCHEMBL8075804 0.80 KCNH2 (0.57) KCNH2P2RX7SIGMAR1CCKBR
SCHEMBL7816348 0.80 KCNH2 (0.46) KCNH2P2RX7TNKSTNKS2PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832075-B1 N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 2000-10-11 EP claimed
EP-0832075-A4 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 1998-10-07 EP claimed
EP-0832075-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES Merck & Co., Inc. (US) 1998-04-01 EP claimed
US-5691331-A N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides MERCK & CO., INC. (US) 1997-11-25 US claimed
WO-1996040655-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO., INC. (US) 1996-12-19 WO claimed
EP-0832075-B1 N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 2000-10-11 EP disclosed
EP-0832075-A4 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 1998-10-07 EP disclosed
EP-0832075-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES Merck & Co., Inc. (US) 1998-04-01 EP disclosed
US-5691331-A N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides MERCK & CO., INC. (US) 1997-11-25 US disclosed
WO-1996040655-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO., INC. (US) 1996-12-19 WO disclosed